Nebulized ketamine for moderate to severe asthma attacks
Part of Immune system & allergy, Lungs & breathing clinical trials.
This study tests whether adding a nebulized medication called ketamine to standard asthma treatment helps people having a moderate to severe asthma attack breathe better. Ketamine is usually used as an anesthetic, but in this form it may help relax the airways.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You are having a moderate to severe asthma attack that requires emergency care.
- Your peak flow (a measure of how well you can blow air out) is between 33% and 75% of your usual best.
- You are awake, alert, and able to give consent.
- You do not need a breathing tube or emergency ventilation (a machine to help you breathe).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether giving ketamine as a mist through a nebulizer can help children with severe asthma attacks breathe easier. It is for children aged 1 to 13 who have already received standard treatments but still have severe symptoms.
This trial tests if a ketamine mist you breathe in can help treat moderate to severe depression. It is for adults who are not helped enough by other treatments.
This study tests whether ketamine, a sedative and painkiller, works better than usual sedatives in ICU patients who need help breathing. If you qualify, taking part may help reduce the amount of other sedatives you need.
This study tests whether low-dose ketamine infusions can reduce depressive symptoms in patients staying in the intensive care unit for at least 6 days. Ketamine is a medication that may work differently than standard antidepressants and could provide faster relief.
This trial tests if a single dose of ketamine can quickly reduce suicidal thoughts in people who come to the emergency department. If you are having active suicidal thoughts and need inpatient care, you may be able to join.
This study tests whether a ketamine nasal spray can help reduce depression and anxiety in people with advanced cancer. It also looks at how caregivers are affected. If you are living with progressive cancer and feeling down or anxious, this treatment might offer some relief.
Hear when a new Asthma Acute trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.